Utility of LHRH antagonists for advanced prostate cancer.
CONCLUSIONS: The rapid T-suppression achieved with degarelix may provide a clinical benefit for various groups of men with advanced or locally advanced disease.
PMID: 24775720 [PubMed - in process]
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research
More News: Abarelix | Cancer | Cancer & Oncology | Hormones | Prostate Cancer | Study | Urology & Nephrology